Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma (MEMMAT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Medical University of Vienna
Information provided by (Responsible Party):
Andreas Peyrl, Medical University of Vienna Identifier:
First received: May 17, 2011
Last updated: July 28, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2022
  Estimated Primary Completion Date: April 2019 (Final data collection date for primary outcome measure)